Abstract:RNA interference (RNAi) is widely used to suppress gene expression in a specific manner. The efficacy of RNAi is mainly dependent on the sequence of small interfering RNA (siRNA) in relation to the target mRNA. Although several algorithms have been developed for the design of siRNA, it is still difficult to choose a really effective siRNA from among multiple candidates. In this article, we report the development of an image-based, quantitative, ratiometric fluorescence reporter assay to evaluate the efficacy of RNAi at the single-cell level. Two fluorescence reporter constructs are used. One expresses the candidate small hairpin RNA (shRNA) together with an enhanced green fluorescent protein (EGFP); the other expresses a 19-nt target sequence inserted into a cassette expressing a red fluorescent protein (either DsRed or mCherry). Effectiveness of the candidate shRNA is evaluated as the extent to which it knocks down expression of the red fluorescent protein. Thus, the red-to-green fluorescence intensity ratio (appropriately normalized to controls) is used as the read-out for quantifying the siRNA efficacy at the individual cell level. We tested this dual fluorescence assay and compared predictions to actual endogenous knockdown levels for three different genes (vimentin, lamin A/C and Arp3) and twenty different shRNAs. For each of the genes, our assay successfully predicted the target sequences for effective RNAi. To further facilitate testing of RNAi efficacy, we developed a negative selection marker ( ccdB ) method for construction of shRNA and red fluorescent reporter plasmids that allowed us to purify these plasmids directly from transformed bacteria without the need for colony selection and DNA sequencing verification.

A novel siRNA validation system for functional screening of effective RNAi targets in mammalian cells and development of a derivative lentivirus delivery system

Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.

A novel system for rapid screening of effective siRNA target sites by one step transfection with a single vector.

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

An image-based, dual fluorescence reporter assay to evaluate the efficacy of shRNA for gene silencing at the single-cell level

Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (sirnas) in Mammalian Cells

In Vivo Dendritic Cell-specific Gene Silencing Using a Novel and Selective Sirna Delivery Method to Induce Immune Modulation

Modulation of Gene Expression by Lentiviral-Mediated Delivery of Small Interfering RNA

Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: A promising approach to Combat viral mutants, with a focus on HIV-1

Development of in Silico Methodology for Sirna Lipid Nanoparticle Formulations

An Automated High-Throughput Fluorescence In Situ Hybridization (FISH) Assay Platform for Use in the Identification and Optimization of siRNA-Based Therapeutics

Development and Validation of Vectors Containing Multiple Sirna Expression Cassettes for Maximizing the Efficiency of Gene Silencing.

In vivo self-assembled small RNAs as a new generation of RNAi therapeutics

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.

A Method for Detecting and Preventing Negative RNA Interference in Preparation of Lentiviral Vectors for Sirna Delivery

Single siRNA nanocapsules for enhanced RNAi delivery.

Interference RNA induction and drug target validation

Establishment of experimental aminal model of RNAi in vivo using lentivirus-siRNA vector system targeting TFAM

Construction and Biological Evaluation of a Novel Integrin Ανβ3-Specific Carrier for Targeted Sirna Delivery in Vitro

An Efficient and Multiple Target Transgenic RNAi Technique with Low Toxicity in Drosophila

Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer